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ABSTRACT
Poly(ADP-ribosyl)ation regulates numerous cellu-
lar processes like genome maintenance and cell
death, thus providing protective functions but also
contributing to several pathological conditions.
Poly(ADP-ribose) (PAR) molecules exhibit a remark-
able heterogeneity in chain lengths and branching
frequencies, but the biological significance of this
is basically unknown. To unravel structure-specific
functions of PAR, we used PARP1 mutants produc-
ing PAR of different qualities, i.e. short and hy-
pobranched (PARP1\G972R), short and moderately
hyperbranched (PARP1\Y986S), or strongly hyper-
branched PAR (PARP1\Y986H). By reconstituting
HeLa PARP1 knockout cells, we demonstrate that
PARP1\G972R negatively affects cellular endpoints,
such as viability, cell cycle progression and geno-
toxic stress resistance. In contrast, PARP1\Y986S
elicits only mild effects, suggesting that PAR branch-
ing compensates for short polymer length. Inter-
estingly, PARP1\Y986H exhibits moderate benefi-
cial effects on cell physiology. Furthermore, differ-
ent PARP1 mutants have distinct effects on molec-
ular processes, such as gene expression and pro-
tein localization dynamics of PARP1 itself, and of its
downstream factor XRCC1. Finally, the biological rel-
evance of PAR branching is emphasized by the fact
that branching frequencies vary considerably during
different phases of the DNA damage-induced PARy-
lation reaction and between different mouse tissues.
Taken together, this study reveals that PAR branch-
ing and chain length essentially affect cellular func-
tions, which further supports the notion of a ‘PAR
code’.
INTRODUCTION
The post-translational modification poly(ADP-
ribosyl)ation (PARylation) plays key roles in cellular
physiology and stress response. The modification is cat-
alyzed by members of the family of poly(ADP-ribose)
polymerases (PARPs, also known as ARTDs) (1). It is
involved in a host of cellular functions including genome
maintenance, transcription, chromatin remodeling, stress
response and regulation of cell death (2). Importantly,
PARPs represent promising targets in cancer therapy,
either as chemosensitizers in combination with classical
DNA damaging chemotherapeutics or as stand-alone
drugs for tumors deficient in homologous recombination,
following the concept of synthetic lethality (3,4).
The PARP gene family consists of 17 homologs in hu-
mans, where at least four of the encoded enzymes pro-
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duce poly(ADP-ribose) (PAR) by using NAD+ as a sub-
strate, while the remaining members catalyze mono- and
oligo(ADP-ribosyl)ation, or are catalytically inactive (5).
Of those that produce PAR, PARP1 and PARP2 localize to
the nucleus and can be activated by several forms of DNA
damage, but in particular by DNA strand breaks. PARP1,
which is responsible for ∼90% of genotoxic stress-induced
PAR formation, produces PAR chains of up to 200 ADP-
ribosyl units, which can be either linear or branched, and
which are linked via -O-glycosidic (1′′-2′) ribose-ribose
bonds or -O-glycosidic (1′′′-2′′) ribose-ribose bonds, re-
spectively (6). After PARP1 activation, target proteins are
covalently modified with PAR at serine, glutamate, aspar-
tate, lysine and tyrosine residues (7–12). One major tar-
get of PARylation is PARP1 itself (i.e. ‘PARP1 automod-
ification’) (13), leading to changes in PARP1’s DNA bind-
ing ability and its catalytic activity (14,15). It has been re-
ported that PARP1 can be active as a monomer or a dimer,
resulting in PARylation in cis or in trans (16–22). Apart
from covalent modification, proteins can also be regulated
via non-covalent binding to PAR chains (23,24). Several
different PAR binding motifs were identified, which me-
diate high-affinity PAR–protein interactions (25). Among
those are the ‘classical’ PAR-binding motifs (PBMs) (26),
as well as glycine- and arginine-rich domains (GAR) (27),
PAR-binding zinc fingers (PBZ) (28), macrodomains (29)
or WWE-domains (30). Like other post-translational mod-
ifications, PARylation is tightly regulated by catabolizing
enzymes such as PARG and others, which hydrolyze PAR
shortly after its synthesis (5,31). Thereby, physico-chemical
properties, as well as spatio-temporal activities of hun-
dreds of target proteins are dynamically regulated. PARP1-
dependent PARylation is linked to pleiotropic cellular func-
tions, yet in particular to the DNA damage response. There-
fore, PARP1 was proposed as a caretaker of genomic sta-
bility (32,33). The recruitment of PARP1 to DNA lesions
is one of the fastest cellular responses upon genotoxic
stress and PARP1-mediated PARylation orchestrates many
downstream DNA damage response processes (14,34,35).
Furthermore, PARP1 is involved in chromatin regulation
(33,36), telomere maintenance (37,38), replication (39), cell
cycle control (40), inflammation and immunity (41,42) and
cell death (43).
Biochemical data support the existence of a so-called
‘PAR code’, i.e. the hypothesis that PAR chains of spe-
cific lengths and branching frequencies exert specific func-
tions (44–48). Thus, some proteins, such as histones, p53
or XPA, prefer binding to PAR chains of specific lengths
(44,46,49,50). Moreover, PAR branching may serve as a
recognition site for non-covalent protein binding and it has
been reported that certain PAR-binding proteins, such as
histones, show a preference for branched PAR (49). Intrigu-
ingly, a recent study revealed that the tandem PBZ domains
of the histone chaperone APLF specifically recognize PAR
branching points, which appears to be important for the re-
moval of histone H3 upon DNA damage (51). Furthermore,
the latter study also showed that PARP2 produces branched
PAR chains at higher frequency compared to PARP1 (51),
while on the contrary, TNKS1 was reported to produce
only linear PAR chains (52). In addition to PARP isoform-
specific effects, PAR branching and chain length may also
be regulated by intracellular NAD+ levels (53) as well as
post-translational modifications, which has not been eval-
uated so far. Moreover, not only protein binding properties
appear to be influenced by PAR chain length and branch-
ing, but also the stability of the polymer is potentially de-
termined by its structure. Thus, previous results suggested
that long PAR molecules are degraded faster by PAR catab-
olizing enzymes than shorter ones (54). Furthermore, PAR
branching may lead to stabilization of the PAR structure,
since PARG appears to prefer linear to branched PAR for
degradation (55,56). Despite these interesting initial find-
ings, the cellular and organismic relevance of the hetero-
geneity in PAR chain length and branching is largely un-
explored.
Here, we address the role of PAR heterogeneity on cel-
lular physiology by combining a genetic approach with
the analysis of select cellular and biochemical endpoints.
To this end, we reconstituted HeLa PARP1 knock-out
(KO) cells (34) with different PARP1 variants, which pro-
duce PAR of different qualities with respect to chain
length and branching (57). We chose three different vari-
ants that were reported to synthesize either short PAR
(PARP1\Y986S), hyperbranched PAR (PARP1\Y986H) or
hypobranched PAR (PARP1\G972R) (57) and performed
a comprehensive analysis of the biochemical properties of
PAR in vitro and in cells, as well as of the resulting cellular
consequences.
MATERIALS AND METHODS
Purification of recombinant PARP1 variants
Human recombinant (rec.) PARP1\WT, PARP1\G972R,
PARP1\Y986H and PARP1\Y986S were purified as de-
scribed previously (15,58), with some modifications. All
steps were performed at 4◦C. Bacterial pellets [Escherichia
coli Rosetta 2 (DE3)] were resuspended in 25 mM HEPES
(pH 8.0), 500 mM NaCl, 0.5 mM DTT and 10 mM ben-
zamide and stored at –80◦C. After thawing, the bacterial
suspension was supplemented with 0.1% NP-40, Complete
protease inhibitor (Roche), and 1 mg/ml lysozyme. This
was followed by sonication (4 × 20 pulses), the addition
of 10 g/ml DNaseI and incubation for 1 h. Cellular de-
bris was removed by centrifugation (2 h at 50 000 × g).
The supernatant was filtered and injected into an ÄKTA
FPLC system equipped with a 1-ml HisTrap HP column
(GE Healthcare). This was followed by washing with 10 ml
low-salt buffer [25 mM HEPES (pH 8.0), 500 mM NaCl],
10 ml high-salt buffer [25 mM HEPES (pH 8.0), 1 M NaCl]
and again 10 ml low-salt buffer. Finally, PARP1 was eluted
with 30 ml elution buffer [25 mM HEPES (pH 8.0), 500 mM
NaCl, 500 mM imidazole]. In the next step, the eluted pro-
tein fractions were diluted with 10 ml no-salt heparin buffer
[50 mM Na-phosphate (pH 7), 1 mM EDTA] and loaded
onto a 1-ml heparin HP column (GE Healthcare). PARP1
was eluted with 30 ml NaCl using a gradient up to a con-
centration of 1 M. PARP1 containing fractions were fur-
ther purified via size-exclusion chromatography (HiLoad
16/600 Superdex 200, GE Healthcare) in 50 mM Tris (pH
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Differential scanning fluorimetry
Melting temperatures of rec. PARP1 variants were de-
termined as described previously (59). Briefly, 0.1 mg/ml
PARP1 was incubated for 10 min at room temperature (RT)
in 50 mM Tris (pH 8.0), 150 mM NaCl and 0.5 mM DTT.
To analyze the effect of DNA/NAD+ binding and/or auto-
PARylation, the samples were supplemented with 5 mM
MgCl2, 5 M EcoRI double-stranded DNA linker oligonu-
cleotide (TTCCGGAA) and/or 100 M NAD+ and in-
cubated for 20 min at RT. All samples were mixed with
SYPRO Orange solution (ThermoFisher) and fluorescence
signals were measured in a quantitative real-time CFX con-
nect thermocycler (BioRad, TET channel) using a gradient
from 20◦C to 95◦C at 1◦C/min steps.
In-vitro PAR synthesis and purification
PAR of PARP1\WT and mutants was synthesized and pu-
rified as previously described (23,44). Rec. PARP1 (150 nM)
was incubated in 100 mM Tris (pH 7.8), 10 mM MgCl2 and
1 mM DTT supplemented with 300 g/ml histone H2a,
50 g/ml EcoRI double-stranded DNA activator oligonu-
cleotide (TTCCGGAA) and 1 mM NAD+ in a total volume
of 5 ml at 37◦C for 45 min to produce PAR. The reaction was
stopped by the addition of 5 ml ice-cold 20% TCA, followed
by incubation on ice for 15 min. PAR chains were separated
from proteins by alkaline treatment (0.5 M KOH, 50 mM
EDTA) for 10 min. Afterwards, pH was adjusted to 7.5–8.0
and DNA was digested by the addition of 50 mM MgCl2
and 50 g/ml DNaseI and subsequent incubation at 37◦C
for 2 h. Proteins were digested via the addition of 1 mM
CaCl2 and 50 g/ml proteinase K and subsequent incuba-
tion at 37◦C overnight. The next day, PAR was further pu-
rified via two steps of phenol/chloroform/isoamyl-alcohol
(Roth) extraction and one step of chloroform extraction fol-
lowed by ethanol precipitation. To remove residual phenol,
buffer was exchanged via Vivacon 2 columns (2000 MWCO,
Sartorius).
Mass spectrometric analysis of in-vitro generated PAR
Purified PAR was digested with alkaline phosphatase and
phosphodiesterase to nucleosides. Digested PAR (2.5 pmol)
was subjected to UPLC–MS/MS analysis and adenosine
(Ado), ribosyl-adenosine (R-Ado) and diribosyladenosine
(R2-Ado) were analyzed as described previously (60,61).
Analysis of chain length distribution of in-vitro generated
PAR via HPLC
Purified PAR was separated via an Agilent 1100 HPLC sys-
tem equipped with a DNA Pac PA-100 (ThermoFisher) an-
alytical column. PAR (100 l of a 100-M solution) was
loaded and eluted with increasing NaCl concentrations as
published previously (23,44). Buffer A consisted of 25 mM
Tris pH 9.0 and buffer B consisted of 25 mM Tris pH 9.0
and 1 M NaCl. The program was set as follows: 0 min
(0% B), 3 min (20% B), 20 min (35% B), 40 min (42% B),
70 min (47% B), 110 min (53% B), 120 min (61% B), 131
min (70% B), 132 min (100% B), 152 min (100% B). Elu-
tion of PAR was detected by measuring the absorbance at
258 nm.
PARP1 automodification assay
Rec. PARP1 (1 pmol) was pre-incubated in 9 l buffer [50
mM Tris (pH 8), 150 mM NaCl, 5 mM MgCl2, 0.5 mM
DTT] in the presence or absence of 50 pmol EcoRI double-
stranded DNA activator oligonucleotide (TTCCGGAA)
for 10 min at 25◦C. The PARylation reaction was started
by the addition of 1 l [TAMRA-labeled NAD+]/[NAD+]
(1/10) at a final concentration of 100 M (62). Reactions
were stopped by the addition of SDS loading dye and subse-
quent heating at 95◦C. Samples were separated on gradient
gels (4–20%, Bio-Rad) and visualized on a Typhoon FLA
9000 bioimager (GE Healthcare).
PAR degradation assay
The degradation of PAR by PARG was analyzed using
a previously published method (63). Briefly, 5 nmol PAR
was pre-incubated for 5 min at 37◦C in 55 l PARG as-
say buffer [50 mM KCl, 50 mM KH2PO4 (pH 7.2)]. The
reaction was started by the addition of 10 l rec. human
PARG (AdipoGen) to a final concentration of 60 pg/l. Re-
actions were stopped simultaneously by the addition of 48
l 2.5 M KOH and 48 l 250 mM benzamidine and subse-
quent incubation at 110◦C for 10 min. After cooling, sam-
ples were centrifuged for 5 min at 17 000 × g. A volume
of 50 l was loaded in triplicates into a 96-well half-area
plate (Corning) and analyzed via a TECAN infinite F200
PRO plate reader (ex = 340 nm/em = 440 nm). To quan-
tify the generated ADP-ribose units, a calibration curve
was included in each experiment. Therefore, 65 l of ADP-
ribose of different concentrations (0, 4, 8, 12, 20, 40, 60, 80
M) was supplemented with 48 l 2.5 M KOH and 48 l
250 mM benzamide and treated the same way as the PAR
samples.
Purification of cellular PAR for mass spectrometric analysis
HeLa WT and PARP1 KO cells were seeded in 6-well
plates and transfected with different eGFP-N1::PARP1
constructs. Forty hours after transfection, cells were treated
either with 500 M H2O2 for 5 min or not treated. Cells
were lysed by addition of ice-cold TCA, PAR was purified,
digested to nucleosides, and R-Ado and R2-Ado were quan-
tified as described previously (60,61).
Cell culture, transient transfection, and treatment with PARP
inhibitor
HeLa WT and PARP1 KO cells were cultured at 37◦C, 5%
CO2 and 95% humidity in DMEM (Gibco) supplemented
with 10% fetal bovine serum (Biochrom), 90 U/ml peni-
cillin, 90 g/ml streptomycin (Gibco) and 2 mM glutamine
(Gibco). For transient transfections with the PARP1-eGFP
constructs, Effectene transfection reagent (Qiagen) was
used according to the manufacturer’s instruction, except for
the amount of Effectene, which was reduced by 50%. Treat-
ment with 10 M ABT888 (Selleckchem) was performed
immediately before transfection and cells were incubated
with ABT888 until harvesting. To determine transfection
efficiencies, transfected HeLa PARP1 KO cells were har-
vested with trypsin-EDTA (Gibco), pelleted by centrifu-
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or in FACS-buffer [PBS, 0.5 mM EDTA, 1% (v/v) BSA].
Samples were analyzed using FACSCalibur (BD), FACS-
Fortessa (BD) or FACSVerse (BD) instruments, depending
on the experiment.
CRISPR/Cas9-mediated generation of a PARP1/XRCC1
double KO cell line
To delete functionality of the XRCC1 gene locus, gRNA
oligonucleotides were designed to target exon 1 of XRCC1
and then assembled into a plasmid for transfection via the
GeneArt CRISPR Nuclease Vector with OFP Reporter Kit
(ThermoFisher). HeLa PARP1 KO cells were transfected
with the targeting plasmids using Lipofectamine 2000 trans-
fection reagent (ThermoScientific). Transfected cells were
single-cell sorted using the FACSAria Cell Sorter (BD).
Expanded cellular clones were then harvested, potential
knockouts were screened via western blot analysis and sub-
sequently validated via DNA sequencing.
Detection of PAR, XRCC1 and fibrillarin by fluorescence mi-
croscopy
HeLa WT and PARP1 KO cells were seeded on glass cover
slips in 12-well plates. If required, cells were transiently
transfected with the eGFP-N1::PARP1 constructs. Cells
were treated with H2O2 either 24 or 40 h after transfec-
tion or not treated. Concentration and duration of treat-
ment varied depending on the experiment as indicated.
Treatment was followed by fixation of the cells with 4%
paraformaldehyde in PBS (containing 10 M ABT888 for
staining with XRCC1 and fibrillarin) for 20 min. The reac-
tion was stopped by washing with 100 mM glycine, followed
by washing with PBS and permeabilization for 3 min with
0.4% Trition-X100 in PBS. The cells were washed for 5 min
in PBS (30 min when stained for XRCC1 and fibrillarin),
followed by blocking in PBS containing 20% (w/v) non-fat
milk powder and 0.2% (v/v) Tween20 (PBSMT). Primary
antibodies were diluted in PBSMT as follows: mouse-anti-
PAR [10H, purified from culture supernatant of hybridoma
cells, according to (64), 1:300], rabbit-anti-XRCC1 (Enzo
Life Sciences, 1:1000) and mouse-anti-fibrillarin (Abcam,
1:1000). The cells were incubated with the respective pri-
mary antibody either for 1 h at 37◦C or overnight at 4◦C.
The slides were washed three times in PBS for 10 min and in-
cubated with secondary antibodies for 1 h at 37◦C. The sec-
ondary antibodies were diluted as follows: Alexa546 (Ther-
moFisher, 1:400 or 1:600) and Alexa647 (ThermoFisher,
1:400) both in PBSMT. The slides were washed three times
in PBS for 10 min followed by staining with 0.1 mg/l
Hoechst33342 in PBS for 5 min. This was followed by wash-
ing the cells three times for 10 min in PBS and mounting
of the glass slides using Aqua Poly Mount (Polyscience).
Microscopic images were acquired using either a Zeiss Ax-
iovert 200M widefield microscope (for PAR detection) or a
Zeiss LSM700 confocal microscope (for XRCC1 and fibril-
larin detection). Image data was analyzed using automated
KNIME workflows as described previously (34,65). Only
cells with a GFP fluorescence signal >1.5-fold of the mean
background fluorescence were considered as GFP-positive
and thus analyzed for PAR, XRCC1 and fibrillarin.
NAD+ cycling assay
HeLa WT and PARP1 KO cells were seeded in 6-well plates
and transfected with the eGFP-N1::PARP1 constructs as
indicated. Forty hours after transfection, cells were either
treated for 7 min with 500 M H2O2 or not treated. Af-
ter treatment, cells were washed once with PBS and de-
tached with trypsin–EDTA (Gibco). The harvested cells
were counted, and 2 × 106 cells were used for extraction
of NAD+. The cells were pelleted and resuspended in pre-
cooled PBS, lysed by addition of 24 l 3.5 M perchloric acid
and incubation for 15 min on ice. Cellular debris was re-
moved via centrifugation for 10 min at 1500 × g and the
supernatant was mixed with 350 l phosphate buffer (0.33
M K2HPO4, 0.33 M KH2PO4, pH 7.5) followed by incu-
bation for 15 min on ice. To clear precipitates, the samples
were centrifuged twice for 10 min at 1500 × g with a 20-min
incubation on ice in between. As reference for the NAD+ cy-
cling assay, a standard curve with NAD+ concentrations up
to 0.48 M was prepared for each experiment. Each sample
was measured in technical triplicates. To this end, either 200
l of the standards or 40 l of the samples diluted with 160
l diluent (0.5 M H3PO4, 0.5 M NaOH) were distributed in
a 96-well flat bottom plate (Corning). To each well, 100 l
reaction mix [0.48 M bicine (pH 8.0), 4 mg/ml BSA, 0.02 M
EDTA, 2.4 M ethanol, 2 mM MTT, 0.96 mg alcohol dehy-
drogenase and 5.7 mM phenazine ethosulfate] were added.
Absorption was measured at 550 nm after 30 min of incu-
bation at 30◦C using 690 nm as a reference wavelength. The
intracellular NAD+ amount (n) was calculated according to
the standard curve and was normalized to transfection ef-
ficiencies determined by FACS analysis. The following for-
mula was used:
n[NAD+] = n[NAD+ in PARP1 KO cells] · (1 − [transfection efficiency])
+n[NAD+ in transfected cells] · [transfection efficiency].
Analysis of cell viability using Annexin V/PI staining
HeLa WT and PARP1 KO cells were seeded in 6-well
plates and transfected with different eGFP-N1::PARP1
constructs as indicated. Twenty-four hours after transfec-
tion, the cells were either treated with various concentra-
tions of camptothecin (CPT; Sigma-Aldrich) for 40 h or
not treated. Afterwards, cells were harvested using trypsin-
EDTA (Gibco) and 2.5 × 105 cells were used for analysis.
The cells were pelleted and resuspended in 250 l Annexin
V-binding buffer [10 mM HEPES pH 7.4, 140 mM NaCl,
2.5 mM CaCl2]. A volume of 195 l of the cell suspen-
sion was mixed with 2.5 l Annexin V-APC (Enzo Life Sci-
ences) and incubated for 15 min in the dark. A volume of
200 l propidium iodide solution (10 g/ml PI in Annexin
V-binding buffer) was added and the samples were analyzed
using a FACSCalibur instrument (BD). For each sample, 10
000 transfected cells were analyzed, and only GFP-positive
cells were included in the analysis.
Analysis of cell proliferation
HeLa PARP1 KO cells were seeded in six-well plates and
transfected with different eGFP-N1::PARP1 constructs.
Forty hours after transfection, cells were harvested with
trypsin-EDTA (Gibco) and incubated with CellTrace violet
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Three hundred thousand cells were seeded in 6-cm plates
and allowed to grow for 5 days. Immediately after staining,
the remaining cells, corresponding to the time point t0, were
analyzed using a FACSFortessa instrument (BD). For ex-
clusion of dead cells, SytoxRed dead cell stain (Invitrogen)
was used in a 1:1000 dilution. For tracing proliferation, cells
were harvested using trypsin-EDTA, stained with SytoxRed
dead cell stain and analyzed every 24 h (time points t1–t5).
Colony formation assay
HeLa WT and PARP1 KO cells were seeded in six-well
plates and transfected with various eGFP-N1::PARP1 con-
structs. Forty hours after transfection, cells were treated
with different concentrations of H2O2 for 5 min and
harvested with trypsin-EDTA (Gibco), pelleted, and re-
suspended in phenolred-free medium containing 1:1000
SytoxRed dead cell stain (Invitrogen). For each sample 1000
GFP-positive cells were sorted using a FACSAria instru-
ment (BD) in each well of six-well plates. Plates were incu-
bated for one week at 37◦C at 5% CO2 before fixation with
PFA and staining with crystal violet. All colonies larger
than 100 cells were included in the analysis.
Cell cycle analysis
HeLa WT and PARP1 KO cells were seeded in six-well
plates and transfected with various eGFP-N1::PARP1 con-
structs. Twenty-four hours after transfection, cells were
treated with different concentrations of camptothecin
(CPT, Sigma-Aldrich) and incubated for 40 h. For the PI
staining, cells were harvested with trypsin-EDTA (Gibco),
pelleted and resuspended in 300 l ice-cold PBS. Ice-cold
ethanol (700 l) was added and samples were incubated
for 20 min on ice. Then, cells were washed once with PBS
and resuspended in 30 l PBS. DNA extraction buffer [120
l; 4 mM citric acid, 0.2 M Na2HPO4 pH 7.8] was added
and samples were incubated for 20 min at room temperature
on a shaker. Afterwards, cells were pelleted, resuspended in
DNA staining buffer [PBS, 0.2 mg/ml RNase A (Thermo
Scientific), 20 g/ml propidium iodide (Sigma-Aldrich)],
incubated for 30 min at RT in the dark and analyzed using a
FACSCalibur instrument (BD). In case of transfection ex-
periments, only GFP-positive cells were analyzed.
Western blot analysis of protein expression
All cell lines were seeded in six-well plates. HeLa PARP1
KO cells were transfected with various eGFP-N1::PARP1
constructs as indicated. Furthermore, as indicated, treat-
ment with ABT888 was performed immediately before
transfection and cells were incubated with ABT888 un-
til harvesting. Cells were harvested with trypsin-EDTA
(Gibco), pelleted and resuspended in PBS and SDS load-
ing dye to a concentration of 1 × 106 cells per 100 l.
Subsequently, samples were heated at 95◦C for 5 min and
20 l (i.e. corresponding to 2 × 105 cell equivalents) were
loaded onto SDS gels (10 or 12%). Western blots were
performed using 0.45 m nitrocellulose membranes (GE
Healthcare), unspecific binding sites on membranes were
blocked with 5% milk in TBS-T [150 mM NaCl, 10 mM
Tris base (pH 8), 0.05% Tween20], and membranes were
subsequently incubated with the respective primary anti-
bodies either for 1 h at RT or overnight at 4◦C: mouse-
anti-PARP1 (CII10, purified from culture supernatant of
hybridoma cells, 1:300), rabbit-anti-XRCC1 (Enzo Life
Sciences, 1:1000) and mouse-anti--actin (Cell Signaling,
1:1000). Membranes were then incubated with respective
secondary antibodies for 1 h at RT: goat-anti-mouse HRP-
coupled or goat-anti-rabbit HRP-coupled (both Dako,
1:5000). Chemiluminescent signals were visualized on a
ChemiDoc Imaging System (Bio-Rad). The detected signal
for actin as a loading control was corrected according to
the following formula to account for different transfection
efficiencies (TFE): actin corrected = actin detected signal × TFE.
Subsequently, values detected for PARP1 were normalized
to the actin corrected value.
Analysis of protein recruitment to laser-induced DNA dam-
age
HeLa cells bearing a genomic knockout of PARP1 (PARP1
KO) or PARP1 and XRCC1 (PARP1/XRCC1 double KO,
DKO) were seeded in -dishes (Ibidi). Approx. 18 h later,
they were transfected with expression vectors encoding ei-
ther WT or mutant versions of eGFP-N1::PARP1 alone,
or in combination with mRFP-C1::XRCC1. Twenty-four
to forty hours after transfection, medium was replaced
by phenolred-free medium for microscopic analysis. Mi-
croirradiation and subsequent time-lapse imaging was per-
formed using an inverted laser-scanning microscope (Zeiss
LSM700) equipped with a multi-color femtosecond fiber
laser setup (66). In-situ bandwidth-limited optical pulses
with a center wavelength of 1035 nm were focused onto the
sample using a 63× oil immersion objective lens (N.A. 1.4).
The average optical power was between 16 and 18 mW. The
laser was scanned along a 4.6 m long linear path divided
into 52 pixel positions, resulting in a pixel dwell time of 45
ms. In each experiment, at least 27 cells were subsequently
irradiated. The experiments were performed at least three
times on different days. Quantitative image data analysis
of time-series was performed in FIJI with the ImageJ soft-
ware macro BIC Macro Toolkit (BIC toolbox, University
of Konstanz, Germany). The toolbox is available for down-
load at https://www.biologie.uni-konstanz.de/bioimaging-
centre/. To account for different expression levels and to en-
sure better comparability of the different PARP1 variants,
only cells with comparable nuclear fluorescence intensity
values were included in the evaluation.
RT qPCR
HeLa PARP1 KO cells were seeded in six-well plates
and transfected with various eGFP-N1::PARP1 constructs.
Sixty-four hours after transfection, cells were detached with
trypsin–EDTA and 10% of the cells were used for determi-
nation of transfection efficiencies via flow cytometric anal-
ysis. The remaining cells were used for RNA isolation, fol-
lowed by high throughput RT qPCR with Fluidigm dy-
namic arrays on the BioMark system as described previ-
ously (67). A complete list of all analyzed genes is shown
in Supplementary Table S1. To take into account different
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respective genes was adjusted using gene expression values
of PARP1 KO cells, according to the following formula:
valuevariant = [measured valuevariant] − [measured valueKO] · (1 − TFE)TFE .
Statistical analyses
Statistical testing has been performed with GraphPad Prism
8.4 as indicated in individual figure legends, * P < 0.05, **
P < 0.01, *** P < 0.001, ‘n.s.’, non-significant.
RESULTS
Biochemical characterization of PARP1 variants synthesiz-
ing PAR of different chain length and branching
To obtain further insight into the role of the struc-
tural heterogeneity of PAR regarding chain length and
branching in cellular (patho-)physiology, we used differ-
ent PARP1 variants that have been previously reported
to synthesize PAR of different qualities (57). We chose
the variants PARP1\G972R (producing hypobranched
PAR), PARP1\Y986H (producing hyperbranched PAR),
and PARP1\Y986S (producing short PAR). For biochem-
ical characterization and validation of the enzymatic prop-
erties, we purified the respective proteins using an E.
coli expression system and analyzed biochemical proper-
ties of the PARP1 variants themselves, as well as of the
PAR produced by them. To test if amino acid (aa) ex-
changes, which are all located within the catalytic domain
of PARP1 (Figure 1A), affect the structural stabilities of
the proteins, we performed differential scanning fluorime-
try (DSF). PARP1\WT showed a melting temperature of
48◦C (Supplementary Figure S1), which is consistent with
previously published data (68). All three variants showed
a slightly reduced thermal stability with PARP1\G972R
and PARP1\Y986S being somewhat more affected than
PARP1\Y986H (Supplementary Figure S1). This indicates
that the introduced aa exchanges have slight destabilizing
effects on the structure of PARP1––a finding which needs
to be considered when interpreting the results of this study.
Binding of PARP1 to DNA and the resulting destabiliza-
tion of the HD domain are essential for efficient activa-
tion of PARP1 (16,17,69,70). To test for potential effects of
the inserted mutations on PARP1 activation, we performed
DSF experiments in the presence of DNA. As expected,
we observed a slight reduction of the thermal stability of
PARP1\WT in the presence of DNA, which is likely caused
by the previously reported allosteric binding mechanism
(Supplementary Figure S1B) (16,17,69,70). Interestingly,
the observed destabilization effect in the presence of DNA
was even enhanced for all three PARP1 variants. Therefore,
DNA binding and resulting allosteric activation are proba-
bly not impaired by the inserted mutations. To test the en-
zymatic activities of the human recombinant (rec.) PARP1
variants, we performed an automodification assay using
TAMRA-labeled NAD+ (Figure 1B and Supplementary
Figure S2) (71). While PARP1\WT and PARP1\Y986H
strongly modified themselves in a time-dependent man-
ner, the automodification activities of PARP1\G972R and
PARP1\Y986S were considerably reduced. Furthermore,
PARP1\Y986S showed a reduced upwards shift in the gel,
indicating the preferential formation of short PAR chains.
Next, we used rec. PARP1 to synthesize PAR enzymatically,
which was then analyzed regarding branching frequencies
and chain length distributions. The amounts of PAR pro-
duced by the different PARP1 variants confirmed the dif-
ferences in catalytic activities (Figure 1C). The highest
amounts of PAR were obtained from PARP1\WT followed
by PARP1\Y986H. Considerably lower amounts were pro-
duced by PARP1\G972R and PARP1\Y986S. Next, we an-
alyzed branching frequencies of purified PAR. To this end,
PAR was digested to the corresponding nucleosides and R2-
Ado/R-Ado ratios were analyzed using a mass spectromet-
ric approach (60,61) (Figure 1D). In accordance with results
from Rolli et al. (57), PAR produced by PARP1\G972R
exhibited a ∼30% reduced branching ratio in compari-
son to PAR produced by PARP1\WT, whereas PAR from
PARP1\Y986H exhibited a 16-fold increase in branching
ratio. A new finding was that PAR from PARP1\Y986S dis-
played a 1.7-fold increased branching frequency in compar-
ison to PARP1\WT. Finally, we analyzed the chain length
distribution of purified PAR (Figure 1E). For all three mu-
tants, we observed a shift toward shorter chains in com-
parison to PARP1\WT. While PARP1\G972R produced
PAR of medium size, especially PARP1\Y986S produced
PAR of very short chain length. In summary, we generated
and characterized three different non-natural PARP1 vari-
ants, which display distinct catalytic activities and synthe-
size PAR of different chain lengths and branching frequen-
cies. Accordingly, these variants offer a suitable tool to un-
ravel the significance of PAR heterogeneity in a cellular con-
text.
Cellular characterization of PARP1 variants synthesizing
PAR of different chain length and branching
To test if the PARP1 variants produce differentially struc-
tured PAR also in a cellular environment, we transiently
transfected HeLa PARP1 KO cells (34) with C-terminally
eGFP-tagged versions of the different variants. To obtain
sufficient amounts of cellular PAR for LC–MS/MS analy-
sis, we stimulated cells by H2O2 treatment before PAR pu-
rification. Results of this analysis confirmed that all tested
GFP-tagged PARP1 variants were catalytically active, when
expressed in cells. As already seen in vitro, all three vari-
ants displayed a reduced activity, with the strongest re-
duction for PARP1\G972R (Figure 2A). The produced
PAR was further analyzed with regards to branching fre-
quencies by determining the R2-Ado/R-Ado ratio via LC-
MS/MS. Comparable to the analysis of in vitro generated
PAR, PARP1\G972R exhibited a 36% reduced branching
frequency, whereas PARP1\Y986H and Y986S produced
PAR with an ∼11-fold and ∼2-fold increased branching ra-
tio, respectively (Figure 2B). These data were further sup-
ported by the analysis of intracellular NAD+ levels. After
H2O2 treatment, the NAD+ levels decreased in cells trans-
fected with all PARP1 variants, but after treatment with 50
M H2O2 the decrease in NAD+ levels was slightly less pro-
nounced for PARP1\G972R-expressing cells, confirming a
reduced activity of this variant in a cellular environment
(Figure 2C). To further analyze the catalytic activities of
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Figure 1. Biochemical characterization of rec. PARP1 variants. (A) Schematic representation of the domain organization of human PARP1 and crystal
structure of the catalytic domain (PDB code: 5WRQ). Amino acids substituted in the PARP1 variants that are used in this study are highlighted in red,
with the G972R substitution resulting in short and hypobranched, Y986S in short and moderately hyperbranched and Y986H in strongly hyperbranched
PAR chains. The E988K substitution, which results in mono-ADP-ribosyl transferase activity, is highlighted in green. (B) Time-dependent automodifica-
tion reaction of rec. PARP1 variants in the absence or presence of DNA. PARylation was started by the addition of 100 M TAMRA-labelled NAD+
(NAD+:TAMRA-NAD+ = 10:1) and analyzed by SDS-PAGE. Full blots are shown in Supplementary Figure S2. (C) Amount of PAR purified from rec.
PARP1 variants as determined by UV absorption at 258 nm. (D) Mass-spectrometric quantification of the [A.U.C. of R2-Ado]/[A.U.C. of R-Ado] ratio
of PAR generated and purified from rec. PARP1 variants. Means of n=3. Statistical analysis was performed for the whole data set using 1-way ANOVA
testing with Dunnett’s post test (###P < 0.001), or separately between PARP1\WT and each variant using an unpaired t-test (**P < 0.01; ***P < 0.001).
(E) Analysis of chain length distribution of PAR generated and purified from rec. PARP1 variants by HPLC. 10 nmol PAR was loaded respectively.
dynamics, we performed time-course immunofluorescence
analyses using a PAR-specific antibody. We observed simi-
lar formation and degradation dynamics of PAR generated
by the different PARP1 variants compared to PARP1\WT
(Figure 2D and Supplementary Figure S3). Yet, PAR lev-
els in PARP1\G972R-expressing cells decreased at a slower
rate than in cells expressing PARP1\WT and the two other
variants. Moreover, in accordance with the mass spectro-
metric data (Figure 2A), the maximal PAR signals were re-
duced for all PARP1 variants compared to PARP1\WT.
In summary, the PARP1 variants that were chosen for the
comparative analysis of PAR chain length- and branching-
specific cellular effects, were all active in a cellular environ-
ment, and thus represent exquisite tools to analyze cellular
consequences of potential PAR structure-specific effects.
Impact of different PARP1 variants on cellular physiology
PARP1 is involved in diverse cellular processes like DNA
replication, transcription, cell cycle regulation, and regula-
tion of cell death. To determine potential PAR structure-
specific roles in these processes, we reconstituted HeLa
PARP1 KO cells with the different PARP1 variants and
analyzed selected cellular endpoints, such as clonogenic
survival, proliferation, cell cycle progression, and viabil-
ity. As a general, yet very sensitive, read-out for po-
tential alterations of cellular physiology, we performed
clonogenic survival analyses, as this assay takes into ac-
count a spectrum of cellular processes like cell attach-
ment, proliferation and viability (72). Intriguingly, we ob-
served that cells transfected with PARP1\G972R––but
not PARP1\Y986S––formed only half as many colonies
as PARP1\WT-transfected cells. This suggests that hypo-
branched PAR negatively influences cell attachment, prolif-
eration and/or viability. Remarkably, expression of the hy-
perbranching PARP1\Y986H variant led to more colonies
compared to cells expressing PARP1\WT, suggesting a
moderate positive effect of PAR branching on cell attach-
ment and/or proliferation (Figure 3A). To analyze in detail,
which processes are affected by the expression of the differ-
ent PARP1 variants, we measured cell proliferation, using
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Figure 2. Characterization of PAR formation in HeLa PARP1 KO cells reconstituted with different PARP1-eGFP variants. (A) Mass-spectrometric quan-
tification of PAR levels (R-Ado) after treatment with 500 M H2O2 for 5 min. Means ± SEM of n = 3–8 independent experiments, each normalized
to PARP1\WT. Statistical analysis was performed using one-way ANOVA testing with Dunnett’s post-test. (B) Mass-spectrometric quantification of the
[A.U.C. of R2-Ado] / [A.U.C. of R-Ado] ratio of purified PAR after treatment with 500 M H2O2 for 5 min. Means ± SEM of n = 3–8 independent ex-
periments. Statistical analysis was performed for the whole data set using one-way ANOVA testing with Dunnett’s post-test (###P < 0.001), or separately
between PARP1\WT and each variant using an unpaired t-test (*P < 0.05; ***P < 0.001). (C) Intracellular NAD+ levels with or without H2O2 treatment
(concentrations as indicated) for 7 min, as measured by an enzymatic NAD+ cycling assay. Means ± SEM of n = 3–4 independent experiments. Statistical
analysis was performed using two-way ANOVA testing with Sidak’s post test. (D) Single-cell immuno-epifluorescence analysis of PAR-synthesis using the
anti-PAR-specific 10H antibody. Densitometric quantification of epifluorescence imaging data using a KNIME workflow as described in material and
methods. Means ± SEM of n = 3 independent experiments. Statistical analysis was performed using two-way ANOVA testing.
ses revealed that cell growth is delayed in PARP1\G972R-
and mildly affected in PARP1\Y986S-expressing cells. In
contrast, cells expressing the PARP1\Y986H variant dis-
played normal cell growth compared to cells transfected
with PARP1\WT (Figure 3B). This indicates that short and
hypobranched PAR causes a delay in cell growth, whereas
hyperbranched PAR does not influence cell proliferation
under these conditions. The slower proliferation, as ob-
served for PARP1\G972R- and PARP1\Y986S-expressing
cells, points to a deregulated cell cycle progression. To test
this hypothesis, we analyzed the cell cycle profile of HeLa
PARP1 KO cells reconstituted with the different PARP1
variants by PI staining and subsequent flow cytometric
analysis. The results demonstrate that PARP1\G972R-
transfected cells –– but not the PARP1\Y986S-expressing
cells –– indeed accumulated in G2 phase (Figure 3C).
Again, hyperbranched PAR, as present in cells transfected
with PARP1\Y986H, did not change the cell cycle profile.
To test if cell death might also contribute to the strongly re-
duced colony formation of PARP1\G972R-expressing cells,
we analyzed cell viability of transfected cells using An-
nexin V/PI staining and subsequent flow cytometric anal-
ysis. These experiments revealed that cells expressing the
PARP1\G972R variant have a strongly reduced viability
and enhanced levels of apoptosis and necrosis. In con-
trast, cells expressing the PARP1\WT, PARP1\Y986S or
PARP1\Y986H variants showed normal viability and only
very low levels of apoptosis and necrosis (Figure 3D). Im-
portantly, the reduced viability observed for cells trans-
fected with PARP1\G972R could be directly linked to the
synthesis of short and hypobranched PAR chains, as inhi-
bition of PAR formation by the PARP1-inhibitor ABT888
restored normal levels of apoptosis and necrosis (Figure
3D). To investigate the stability of the PARP1 variants in
our cellular system, we analyzed protein expression levels
in cells 24, 48 and 72 h after transfection and compared
untreated cells to those treated with ABT888. Generally,
PARP1 expression decreased over time and expression of
the PARP1/G972R variant was lower than that of the other
variants (Figure 4 and Supplementary Figure S4). We did,
however, not find any significant differences in PARP ex-
pression levels between untreated cells and cells treated with
ABT888. Importantly, this suggests that inhibitor binding
does not stabilize PARP1 levels and is therefore not re-
sponsible for the observed rescue effect in cells transfected
with PARP1\G972R. In summary, these results revealed
that the PARP1 variants producing PAR of different chain
lengths and branching frequencies indeed influence prolif-
eration, cell cycle regulation, and viability. While cells ex-
pressing the hyperbranching PARP1\Y986H variant exhib-
ited enhanced plating efficiencies, especially short and hypo-
branched PAR, as produced by the PARP1\G972R variant,
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Figure 3. Analyses of different endpoints of cellular physiology of HeLa PARP1 KO cells reconstituted with PARP1-eGFP variants. In all cases, PARP1-
reconstituted HeLa PARP1 KO cells were analyzed. (A) Clonogenic survival assay. After transfection, cells were sorted and 100 GFP-positive cells were
plated and cultivated for 7 days prior to colony counting. Means ± SEM of n = 3 independent experiments. [N.B. this data set is part of the experiment
shown in Figure 5A and replotted here for ease of reader friendliness]. (B) Cell proliferation assay via cell trace violet and subsequent flow cytometric
analysis. n = 1. (C) Cell cycle analysis via PI staining and subsequent flow cytometric analysis. Means ± SEM of n = 4 independent experiments. Statistical
analysis was performed using repeated measures one-way ANOVA testing with Dunnett’s post-test. (D) Cytotoxicity analysis via Annexin V/PI staining
and subsequent flow cytometric analysis of cells before and after treatment with 10 M ABT888. Means ± SEM of n = 6 independent experiments for
untreated (including n = 4 values from the experiment shown in Figure 5B) and of n = 2 independent experiments for ABT888 treated cells. Statistical
analysis was performed using two-way ANOVA testing with Sidak’s post-test.
Figure 4. Expression analysis of PARP1-eGFP variants in reconstituted HeLa PARP1 KO cells compared to HeLa WT cells. (A–C) Densitometric analysis
of western blot signal intensities of PARP1 protein levels in HeLa WT or PARP1 KO cells reconstituted with different PARP1 variants (A) 24 h, (B) 48
h or (C) 72 h after transfection. Cells were either untreated or treated with 10 M ABT888 for the indicated duration. Signal intensities were normalized
to transfection efficiencies, to -actin as a loading control and to untreated HeLa WT cells for comparison. Means ± SEM of n = 2–3 independent
experiments. Statistical analysis of ‘untreated’ versus ‘ABT888’ was performed using two-way ANOVA testing with Sidak’s post-test. Representative blots
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Figure 5. Genotoxic stress resistance of HeLa PARP1 KO cells reconstituted with PARP1-eGFP variants. In all cases, PARP1-reconstituted HeLa PARP1
KO cells were analyzed. (A) Clonogenic survival assay upon H2O2 treatment. After transfection and respective H2O2 treatment, cells were sorted and
100 GFP-positive cells were plated and cultivated for 7 days prior to colony counting. Means ± SEM of n = 3 independent experiments. (B) Cytotoxicity
analysis after CPT treatment via Annexin V/PI staining and subsequent flow cytometric analysis. Normalization to DMSO controls is presented in the
right panel. Means ± SEM of n = 4 independent experiments. (C) Effect of CPT treatment on cell cycle progression analyzed via PI staining and subsequent
flow cytometry. Means ± SEM of n = 4 independent experiments. Statistical analysis was performed using two-way ANOVA testing with Sidak’s post-test.
Impact of different PARP1 variants on genotoxic stress re-
sponse
To analyze, to which extent the different PARP1 variants
mediate tolerance to genotoxic stress, we treated PARP1-
reconstituted cells with H2O2 and performed clonogenic
survival assays. Interestingly, the lowest dose of 1 M
H2O2 slightly increased plating efficiencies for all PARP1
variants. Above this concentration, a dose dependent de-
crease in colony formation was observed. Cells express-
ing PARP1\G972R were hardly capable of forming any
colonies after treatment with ≥5 M H2O2 (Figure 5A).
In comparison, cells producing short but branched PAR
by PARP1\Y986S formed colonies up to 50% compared to
PARP1\WT-reconstituted cells, while cells transfected with
PARP1\Y986H, producing short but hyperbranched PAR,
formed up to ∼80% the number of colonies compared to
PARP1\WT. Next, we were interested whether this effect
was also evident after treatment with the topoisomerase I
inhibitor camptothecin (CPT), which induces DNA strand
breaks, protein–DNA adducts and replicative stress. Cells
expressing PARP1\G972R were highly sensitized to CPT
treatment, leading to a reduction to ∼11% viable cells al-
ready at the lowest applied concentration of 1 M (Fig-
ure 5B), which was accompanied by strongly enhanced lev-
els of apoptosis and necrosis. On the contrary, cells ex-
pressing PARP1\WT and PARP1\Y986H displayed 49%
and 44% viable cells at 1 M CPT, respectively. Likewise,
PARP1\Y986S-reconstituted cells also showed reduced vi-
ability compared to PARP1\WT-reconstituted cells, but
the effect was not as pronounced as in PARP1\G972R-
reconstituted cells. Normalization of the results to the re-
spective untreated controls revealed that not only was the
reduced basal viability responsible for the strongly reduced
viability of the PARP1\G972R-reconstituted cells after
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Figure 6. PARP1 recruitment and dissociation at sites of laser-induced DNA damage in HeLa PARP1 KO cells reconstituted with PARP1-eGFP variants.
(A) Representative images. (B) Quantification of recruitment dynamics from image data as shown in (A). Means ± SEM of n = 3 independent experiments,
≥ 42 cells were analyzed per PARP1 variant. Statistical analysis was performed using two-way ANOVA testing. (C) Normalized PARP1 recruitment data
from (A), with maximum intensity values of each curve set to 100%, respectively. Statistical analysis was performed using two-way ANOVA testing.
evident (Figure 5B). Of note, this effect could be completely
rescued by pre-treatment with the PARP-inhibitor ABT888
(Supplementary Figure S5), which again clearly indicates
that the catalytic activity of the PARP1\G972R variant is
responsible for the observed effect. To test if impaired vi-
ability of PARP1\G972R-transfected cells is accompanied
by changes in cell cycle distributions, we investigated cell
cycle profiles after treatment of cells with nanomolar con-
centrations of CPT. For all different PARP1 variants, in-
cluding PARP1\WT, cells underwent a G2 arrest upon CPT
treatment (Figure 5C). Again, the effect was strongest for
PARP1\G972R- and PARP1\Y986S-reconstituted cells, as
already observed for colony forming capacities after H2O2
treatment. In summary, these results demonstrate that the
PARP1 variants producing PAR of different chain length
and branching significantly affect the cellular response and
tolerance to genotoxic stress. Thus, the production of short
and hypobranched PAR considerably impaired the cellular
genotoxic stress response, in contrast to short and moder-
ately or strongly hyperbranched PAR, which showed only
mild or even beneficial effects.
Subnuclear localization of PARP1 variants and XRCC1 upon
induction of DNA damage
Since the expression of the PARP1\G972R and
PARP1\Y986S variants influenced clonogenic survival and
cell cycle progression after genotoxic stress, we analyzed
the recruitment and dissociation behavior of PARP1 at
DNA damage, as these localization dynamics represent one
of the first steps of the PARP1-dependent DNA damage
response (14,34). As expected, PARP1\WT showed a fast
recruitment with maximum signal intensities at the irradi-
ated site after 50 s, followed by relatively fast dissociation
kinetics leading to its almost complete release 400 s post
irradiation (Figure 6A, B). PARP1\Y986H displayed a
behavior similar to PARP1\WT, but with slightly lower
maximum recruitment levels. In contrast, dissociation
of PARP1\Y986S, and especially PARP1\G972R, was
strongly impaired and fluorescence signals did not return
to the levels of the wildtype within the 400-s observation
period. The differences in dissociation kinetics became
more evident when the curves were normalized to the re-
spective maximum intensity values of recruitment (Figure
6C). Additionally, PARP1\G972R showed slower recruit-
ment kinetics, reaching maximum signal intensities at the
irradiated site only after 100 s, compared to 40–60 s for all
other variants. Therefore, recruitment of PARP1 to –– and
dissociation from – DNA damage appears to be directly
connected to PAR quality, leading to longer retention in
case of short and linear PAR chains. As a further cellular
parameter for the functional relevance of PAR chain struc-
ture, we studied the recruitment of the PARP1 downstream
factor XRCC1 to laser-irradiated sites. To eliminate any
possible confounding effects due to the endogenously
expressed protein, we generated HeLa PARP1/XRCC1
double KO (DKO) cells via CRISPR/Cas9-mediated
genome editing (Supplementary Figure S6A). In line with
the recruitment data obtained in reconstituted PARP1
KO cells (Figure 6), we observed a fast recruitment of
PARP1\WT, as well as the Y986H and Y986S vari-
ants, with maximum signal intensities at the irradiated
site after ∼50 s in PARP1/XRCC1 DKO cells. Instead,
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Figure 7. PARP1 and XRCC1 recruitment in HeLa PARP1/XRCC1 double KO cells reconstituted with PARP1-eGFP variants and mRFP-XRCC1. (A)
Quantification of PARP1 recruitment dynamics from image data as shown in Supplementary Figure S6. Means ± SEM of n = 4 independent experiments,
≥52 cells were analyzed per PARP1 variant. (B) Normalized PARP1 recruitment data from (A), with maximum intensity values of each curve set to
100%, respectively. (C) Quantification of XRCC1 recruitment dynamics from image data as shown in Supplementary Figure S6. Means ± SEM of n = 4
independent experiments, ≥52 cells were analyzed per PARP1 variant. (D) Normalized XRCC1 recruitment data from (C), with maximum intensity values
for XRCC1 set to 100% for each condition, respectively. Statistical analysis was performed using two-way ANOVA testing.
(Figure 7A, B). While the overall recruitment kinetics of
the PARP1\G972R variant were similar in PARP1 KO and
double-transfected PARP1\XRCC1 DKO cells, the relative
amount of recruited PARP1\G972R was significantly
higher in the DKO cells (Figure 7A and Supplementary
Figure S6B). A further difference between experiments in
PARP1 KO and PARP1\XRCC1 DKO cells was observed
in the dissociation behavior of the PARP1\Y986H variant,
which resembled PARP1\WT in PARP1 KO cells, while
it entered steady-state levels above those of PARP1\WT
at ∼270 s after irradiation in PARP1\XRCC1 DKO cells
(Figure 7B). The level of recruitment of XRCC1 was
significantly lower in all cells co-transfected with PARP1
mutants as compared to PARP1\WT (Figure 7C and
Supplementary Figure S6B), yet recruitment and dissocia-
tion kinetics were similar in the presence of either PARP1
variant (Figure 7D). Thus, the highest signal of XRCC1
at irradiated sites was observed with PARP1/WT, while
the lowest levels of XRCC1 recruitment was detected with
PARP1\Y986S. The dissociation kinetics of XRCC1 were
slightly, yet significantly, faster in case of reconstitution
with the PARP1\G972R and Y986H variants (Figure 7D).
To gain further insight into the influence of PAR quality
on XRCC1 subnuclear dynamics, we investigated the
translocation of XRCC1 from nucleoli to the nucleoplasm
upon genotoxic stress in cells co-transfected with the
different PARP1 variants by immunofluorescence staining
and subsequent confocal microscopic analysis (Figure 8).
In a previous study, we revealed that XRCC1 translocates
from nucleoli to the nucleoplasm upon H2O2 treatment. In
the presence of PARP1, XRCC1 is retained in the nucleo-
plasm, while in PARP1 KO cells, XRCC1 swiftly relocates
back into nucleoli (65). In accordance with this, Figure 8
shows that in PARP1\WT-reconstituted cells, XRCC1 was
released from nucleoli in response to H2O2-treatment. The
same effect could be observed for both, PARP1\Y986H
and PARP1\Y986S. For PARP1\G972R, however, the
translocation was impaired. This resembles the effect
observed for the previously tested mono-ADP-ribosylating
PARP1\E988K variant, in which case translocation of
XRCC1 was shown to be significantly inhibited, but not
to the same extent as in PARP1 KO cells. This leads to
the assumption that translocation of XRCC1 is at least
partially dependent on the quality of the PAR chains pro-
duced. In summary, recruitment and dissociation kinetics
of PARP1 at sites of laser-induced DNA damage, as well
as recruitment/dissociation kinetics and nucleolar translo-
cation dynamics of XRCC1, are significantly influenced by
PARylation and PAR quality. Altered PARP1 automodi-
fication and impaired downstream signaling events could
therefore at least in part explain the significantly reduced
viability observed for PARP1\G972R-reconstituted cells.
Impact of PARP1 variants on gene expression profiles
To obtain insight into the downstream molecular mecha-
nisms leading to the observed cellular phenotypes, we an-
alyzed expression of a set of 80 genes involved in genome
maintenance, cell death regulation and proliferation in cells
reconstituted with the different PARP1 variants by using a
very accurate and highly sensitive high-throughput qPCR
approach, as described previously (23,67). We indeed ob-
served subtle, yet significant, changes in the expression
profiles for cells reconstituted with the different PARP1
variants in comparison to PARP1\WT-reconstituted cells
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Figure 8. Nucleolar-nucleoplasmic translocation of endogenous XRCC1
in HeLa PARP1 KO cells reconstituted with PARP1-eGFP variants. (A)
Representative images from single-cell immunofluorescence analysis of en-
dogenous XRCC1 translocation from the nucleoli to the nucleoplasm. (B)
Densitometric quantification of confocal imaging data from (A) analyzing
XRCC1 translocation via a KNIME workflow. Means ± SEM of n = 4 in-
dependent experiments. Statistical analysis was performed using two-way
ANOVA testing with Sidak’s post-test.
PARP1\Y986H), most altered genes were slightly down-
regulated (fold regulation < 1.5). The most significant
changes could be observed for growth factors like EGFR
and VEGFA. In contrast, for cells reconstituted with
PARP1\G972R, most altered genes were upregulated. In-
terestingly, especially the expression of genes regulating
apoptosis like BCL2L1 and PMAIP1, cell cycle inhibitors
like TP53 and CDKN1A (p21) and DNA damage repair
genes like RAD51 was significantly increased. This is con-
sistent with the observed cellular phenotype, showing a G2
arrest, increased rates of cell death, and higher sensitivity
Figure 9. Effects of PARP1 variants on expression profiles of an array of 80
genes-of-interest. In all cases, PARP1-eGFP-reconstituted HeLa PARP1
KO cells were analyzed by high throughput RT qPCR. The volcano plots
show the magnitude (fold regulation, x-axis) and the significance (–log10
P-value, y-axis) of gene expression changes between PARP1 KO cells re-
constituted with the respective PARP1 variant compared to cells recon-
stituted with PARP1\WT. Horizontal lines indicate the statistical signifi-
cance threshold (P ≤ 0.05, statistical analysis was performed by an inde-
pendent samples t-test, n = 3 independent experiments); vertical lines indi-
cate no change in gene expression. Genes that are differentially expressed
at a significant level are labelled with the corresponding names. All genes
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Figure 10. Analysis of PAR branching during cellular genotoxic stress response and PARG activity on PAR produced by the different PARP1 variants
in vitro. (A) Mass spectrometric quantification of R-Ado (black) and the [A.U.C. R2-Ado]/[A.U.C. R-Ado] ratio (orange) of PAR purified from HeLa
WT cells after treatment with 500 M H2O2 as indicated. Means ± SEM of n = 3 independent experiments. (B) Time-dependent degradation of PAR
purified from rec. PARP1 variants by PARG. Generated ADP-ribose units were quantified via an ADP-ribose calibration curve as published previously
(89). Background levels of ADP-ribose within the different PAR samples in the absence of PARG are subtracted. Means ± SEM of n = 3–4 independent
experiments. Statistical analysis was performed using two-way ANOVA testing with Sidak’s post-test.
to genotoxic treatment in PARP1\G972R-expressing cells.
In comparison, cells reconstituted with PARP1\Y986S
showed hardly any changes in their expression profile,
suggesting that the observed effects for PARP1\G972R-
reconstituted cells are indeed caused by hypobranched
PAR chains and not only by a reduced chain length,
as PARP1\Y986S produces even shorter chains than
PARP1\G972R. In summary, after reconstitution of HeLa
PARP1 KO cells with the different PARP1 variants, the gene
expression profile indeed changed, providing important in-
dications how changes in PAR structure might be mechanis-
tically connected to the observed cellular phenotypes. Es-
pecially for PARP1\G972R-reconstituted cells, which pro-
duce short, hypobranched PAR, the changes in gene expres-
sion profile directly mirror the observed cellular phenotype.
General significance of PAR branching in cellular and organ-
ismic physiology
As expression of the different non-natural PARP1 variants
pointed to PAR branching-specific effects in cellular func-
tions, we were interested whether PAR branching varies
during genotoxic stress response in HeLa WT cells. To this
end, PAR levels and branching frequencies were analyzed
in HeLa cells at different time points after H2O2 treat-
ment (Figure 10A). Interestingly, the R2-Ado/R-Ado ra-
tios strongly increased between 5 and 7.5 min after treat-
ment, which corresponds to the onset of the catabolic phase
of PARylation dynamics. The increase in branching fre-
quencies was then followed by a decrease until the basal
branching ratio was reached 20 min post treatment. These
results suggest that during the PARylation response, linear
parts of PAR were degraded first, leading to an increase in
the R2-Ado/R-Ado ratio. To follow up on this, we tested
how PARG, which represents the main enzyme responsi-
ble for the degradation of cellular PAR, catabolizes PAR
synthesized by the different non-natural PARP1 variants.
Therefore, in-vitro produced PAR was digested with PARG
for different periods of time and the resulting amounts of
ADP-ribose were quantified (Figure 10B). Hypobranched
PAR, produced by PARP1\G972R, as well as short PAR
chains, produced by PARP1\Y986S, were degraded sig-
nificantly faster than PAR produced by PARP1\WT and
PARP1\Y986H. These results suggest that PARG preferen-
tially degrades short and linear PAR chains, which would be
consistent with the observed increase in PAR branching in
HeLa cells at the early phase of PAR catabolism. In sum-
mary, we demonstrate that PAR branching indeed changes
during the process of PAR degradation after genotoxic
stress-induced PARylation, providing a potential mecha-
nism for the temporal control of PAR structure-specific
downstream processes in cells.
To elucidate a potential in-vivo significance of PAR
branching, we analyzed PAR levels and branching frequen-
cies in 12 different mouse organs. Quantitative analysis by
isotope dilution mass spectrometry revealed that PAR levels
are strongly tissue-dependent. Especially skin, but also mus-
cle, stomach, and brain exhibited high PAR levels. In con-
trast, spleen, lung, small intestine, testis, and colon revealed
very low PAR amounts (Figure 11A). Strikingly, analysis of
branching ratios revealed that PAR branching indeed dif-
fers significantly between different organs. Notably, colon
and stomach had several fold higher R2-Ado/R-Ado ra-
tios compared to all other organs (Figure 11B). Since high
levels of PAR did not correlate with high levels of branch-
ing, it can be assumed that PAR branching does not just
represent a side-product of extensive PAR formation, but is
controlled by distinct underlying regulatory mechanisms in
different cell types (Figure 11A and B). From these data,
we can conclude that physiological PAR levels and PAR
branching frequencies show considerable variability across
different mammalian tissues, pointing towards a biological
significance of PAR heterogeneity on an organismic level.
DISCUSSION
Although PARP1 and PARylation are generally well char-
acterized and their importance, especially with regards to
cancer and DNA repair, is widely accepted, the functions
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Figure 11. Characterization of PAR levels and PAR branching in differ-
ent mouse organs. (A) Mass-spectrometric analysis of PAR-amounts (R-
Ado) purified from mouse tissues as indicated. Means ± SEM of n = 7
mice. Statistical analysis was performed using repeated measures one-way
ANOVA testing with Dunnett’s post-test. (B) Mass-spectrometric analysis
of the [A.U.C. R2-Ado]/[A.U.C. R-Ado] ratio of purified PAR from mouse
tissues as indicated. Means ± SEM of n = 6–7 mice. Statistical analysis was
performed using mixed effects repeated measures analysis with Dunnett’s
post-test. ‘R’ refers to reference organ for statistical testing.
branching are essentially unknown. Results from other
post-translational modifications like the ubiquitin system
indicate the existence of an ‘ubiquitin code’. Here, proteins
can be modified with ubiquitin monomers as well as ubiq-
uitin polymers, which may contain mixed linkages and/or
two or more branches, showing distinct functions depen-
dent on the structure (73,74). These findings indicate that
the structure of a post-translational modification can deter-
mine its functions, supporting the notion of the existence of
a ‘PAR-code’. To address this question, we have character-
ized the functions of PAR chain length and branching on
the cellular level. To this end, we used a HeLa PARP1 KO
cell system reconstituted with different non-natural PARP1
variants that synthesize PAR of different qualities, i.e., with
regards to chain length and branching (34,57).
Our biochemical and cellular characterization of the
PARP1 variants confirmed the formation of distinct PAR
qualities with regards to chain length and branching. In ad-
dition to previous results from Rolli et al. (57), we demon-
strate that PARP1\Y986S not only produces short, but also
moderately (∼2-fold) hyperbranched PAR chains. Com-
bined with the fact that PARP1\Y986H produces 16-fold
higher branching ratios compared to PARP1\WT, our data
indicate that the aa residue Y986 plays a central role in
the branching reaction. This is in accordance with pre-
vious data, proposing that interactions of residue Y986
with the pyrophosphates of the distal ADP-ribose unit of
the acceptor PAR chain stabilize the branching conforma-
tion (6,75). In contrast, the mechanism of aa substitution
G972R, which is located at the surface of the catalytic do-
main, remains elusive. The observed destabilization effect
on the structure of PARP1 suggests an indirectly mediated
defect in elongation and branching. Since PARP1\G972R,
PARP1\Y986S and PARP1\Y986H mainly produce short
PAR chains of similar chain length, but with variable
branching frequencies, those variants are very well suited
to distinguish between the effect of PAR branching and the
effect of PAR chain length when compared to PARP1\WT.
Interestingly, while PARP1\Y986S only mildly affected
cellular physiology, PARP1\G972R displayed a strong phe-
notype affecting clonogenic survival, cell viability, prolifer-
ation, cell cycle progression as well as tolerance to genotoxic
stress. Importantly, those effects could be directly linked
to the formation of short and hypobranched PAR, as they
could be rescued by PARP inhibitor treatment. We can as-
sume that the observed rescue effect is indeed due to the
lack of hypobranched PAR, rather than stabilization of
the G972R variant through inhibitor binding, as expres-
sion levels did not change after inhibitor treatment. No-
tably, PARP1\E988K-reconstituted cells (only performing
MARylation) displayed a similar phenotype, which could
be rescued by PARP inhibitor treatment (34). Therefore, it
can be assumed that not only the complete loss of PARy-
lation ability of PARP1, but already defects in PAR elon-
gation and/or branching capacity can result in severe cellu-
lar effects. Hanzlikova et al. recently showed that PARP1
functions as a sensor of unligated Okazaki fragments, as
PAR was detected at sites of DNA replication during S
phase (39). It would therefore be reasonable to assume that
differentially structured PAR might also influence cellular
physiology at the level of DNA replication, altering the re-
pair of Okazaki fragments not processed by the canoni-
cal pathway. How it might thereby affect cell cycle progres-
sion and potentially manifest in a G2 phase arrest, as seen
for the PARP1\G972R variant, is an intriguing topic for
further studies. The significance of a correct PAR struc-
ture is further demonstrated by a recently described PARP1
knock-in mouse model carrying a point mutation within
the catalytic domain of PARP1 (D993A) (76). Interest-
ingly, the mutation resulted in significantly less branched
PAR (in addition to slightly shorter chain length) com-
pared to PARP1\WT. Of note, those mice were hyper-
sensitive to alkylating agents and showed a similar phe-
notype to PARP1 KO mice. These observations are con-
sistent with our data from PARP1\G972R. Remarkably,
PARP1/Y986H, which produces the strongest alterations
in PAR structure (16-fold higher branching ratio combined
with reduced chain length), showed a similar or even slightly
beneficial phenotype compared to PARP1\WT. Accord-
ingly, significantly higher amounts of branching can be eas-
ily tolerated - at least by HeLa cells - while reduced branch-
ing seems to have severe consequences on cellular phys-
iology. A positive role of branching is further supported
by previous studies, revealing that histones preferentially
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been shown to exhibit histone chaperone activities and
function as an important scaffold protein within the non-
homologous end joining pathway of DNA repair (77,78),
has recently also been reported as a reader of branched PAR
chains (51). Earlier studies already suggested that its tan-
dem PBZ domains are able to bind multiple ADP-ribose
units along a PAR polymer via specific conserved residues
that reduce or abolish PAR binding upon mutation (79,80).
Together, this suggests that branching facilitates chromatin
remodeling, e.g. during DNA damage repair (49,51).
It is generally assumed that automodification of PARP1
results in its dissociation from DNA, which can be inhib-
ited by PARP inhibitor treatment, i.e. a process known
as PARP trapping (81). However, the exact mechanism of
PARP1 dissociation and trapping is still unknown. Laser
microirradiation experiments revealed that PARP1\Y986H
displays similar recruitment and dissociation kinetics to
and from sites of laser-induced DNA damage compared to
PARP1\WT, while dissociation kinetics of PARP1\G972R
and PARP1\Y986S mutants were delayed. Therefore, our
data demonstrate that PARP1 dissociation is not only de-
pendent on PAR formation, but also on the PAR qual-
ity with regards to chain length and branching. As dis-
sociation is probably mainly driven by electrostatic repul-
sion, short and linear PAR chains might not reach the
required threshold. Since high levels of branching seem
to compensate a reduced PAR chain length, this suggests
that not only electrostatic but probably also steric repul-
sion is responsible for PARP1 dissociation. The slight dif-
ferences in PARP1 recruitment we observed between dif-
ferent experiments could be explained by the different sys-
tems we applied to study PARP1 recruitment alone or in
combination with the downstream factor XRCC1. While
our first experiments comprised PARP1 KO cells reconsti-
tuted with eGFP-tagged PARP1 variants, recruitment in
combination with the downstream factor XRCC1 was ana-
lyzed in double-reconstituted PARP1/XRCC1 DKO cells,
using eGPF-tagged PARP1 and mRFP-tagged XRCC1,
in order to avoid possible confounding effects of endoge-
nous PARP1 and XRCC1. Nonetheless, recruitment stud-
ies in both systems consistently showed delayed accumu-
lation of PARP1\G972R at sites of laser-induced DNA
damage compared to the other variants, while dissocia-
tion was decelerated especially for PARP1\G972R and
PARP1\Y986S. The observation that PARP1 recruitment
was delayed for PARP1\G972R, while the velocity of down-
stream XRCC1 recruitment on the other hand was not, sug-
gests that initial PAR formation at the site of DNA damage
is not only necessary for later second-wave recruitment of
PARP1 (14), but might also be sufficient for initial recruit-
ment of the downstream DNA repair factor. PAR struc-
ture and especially chain length however seem essential for
XRCC1 recruitment, as especially PARP1\Y986S was not
able to recruit XRCC1 as efficiently.
Viewed together, our data point towards a regulatory
function of PAR structure in cells. Yet, it remains elusive
how cells can specifically regulate PAR chain length and
branching with spatial as well as temporal resolution. In this
regard, we identified the degradation process as a mecha-
nism for the temporal control of PAR branching frequency.
By using our previously developed mass spectrometric ap-
proach (60,61), we detected an enrichment of branching
points during the catabolic phase of the genotoxic stress-
induced PARylation response in cells, which is in accor-
dance with previous data using low-resolution techniques
(55,56). A plausible reason for an increase of branching
points might be a preferential degradation of linear chains
by PARG. Consistently, results from our in vitro PARG
degradation assay revealed faster degradation for PAR syn-
thesized by PARP1\G972R and PARP1\Y986S in compar-
ison to PAR from PARP1\WT or PARP1\Y986H. This
suggests that degradation efficiency decreases with longer
chains or increasing branching frequencies. This seems con-
tradictory to previous results suggesting an early rapid
degradation of large polymers and a late slow degradation
of small polymers (54). Yet, it was also suggested that PARG
mainly performs endoglycosidic cleavage in the first phase
of cleavage (55), which is not detectable with our in vitro
PARG degradation assay. Still, it is surprising that highly
branched PAR from PARP1\Y986H was degraded with
kinetics similar to PAR from PARP1\WT. This not only
became apparent in the in vitro PARG degradation assay,
but also in the time-course immunofluorescence analyses
of PARP1-reconstituted cells demonstrating similar forma-
tion and degradation kinetics for PAR from PARP1\WT
and PARP1\Y986H. Braun et al. suggested that endogly-
cosidic cleavage of PARG produces linear polymers from
branched polymers, while leaving the branching sites them-
selves intact (55). Accordingly, branching sites might func-
tion as recognition sites for PARG, which trigger endogly-
cosidic cleavage but are not targeted themselves. Thus, an
enrichment of branching points might occur even though
linear and branched chains are degraded with similar effi-
ciencies. Therefore, it is tempting to speculate that branch-
ing points themselves may function as downstream signal-
ing factors. First evidence in this direction is given by Chen
et al., who reported APLF as a factor that binds specifically
to diribosyladenosine and thereby regulates chromatin re-
modeling and DNA damage response (51).
Notably, by analyzing PAR of different mouse organs, we
provide evidence for a biological significance of PAR het-
erogeneity on an organismic level. The finding that PAR
levels did not correlate with branching frequencies suggests
distinct regulatory mechanisms of PAR branching in differ-
ent tissues and cell types. Highest PAR levels were observed
in skin. In accordance with these results, a previous study
identified PAR in human skin with especially high PAR
levels in hair follicle cells (82). It was suggested that high
PAR levels in hair follicle cells occur due to their rapid cy-
cling and the well-known role of PARP1 in cell proliferation
(83). Alternatively, high PAR levels might help to maintain
genomic integrity in epidermal cells, which are constantly
exposed to exogenous stress. Lowest PAR levels were ob-
served in spleen and lung, which is consistent with previous
data on mouse organs (61). Highest branching frequencies
were detected in stomach and colon, suggesting that PAR
branching fulfills distinct functions in cells involved in food
digestion and absorption. Following up on this observation,
the analysis of PAR levels and branching in cell types cor-
responding to the already tested organs would be an im-
portant step to further understand this connection. Simi-
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exogenous stress stimuli. Therefore, not only high levels of
PAR but also high levels of branching might have a protec-
tive function, which would be fully consistent with our data
from cellular studies. Yet, branching ratios were only mod-
erately increased in cells from the small intestine, which is
also part of the gastrointestinal tract. Considering the cen-
tral role of PARPs in genome maintenance, these findings
are consistent with the fact that malignancies of stomach
and colon occur frequently, while malignancies of the small
intestine are very rare. As PARP inhibitors are FDA ap-
proved for the treatment of breast, ovarian and pancreatic
cancers, the future evaluation of PAR levels and branch-
ing in corresponding tissues would be of considerable in-
terest to elucidate the potential link between PARP activ-
ity, PAR quality, tumor formation propensity, and possi-
ble treatment options. Although we can be reasonably sure
about an organismic significance of PAR quality, as of this
moment, we can only speculate about the reasons for vary-
ing PAR levels and PAR branching across different tissues
in vivo. Besides different degradation kinetics of PAR chains
– as mentioned before – the regulation of PARP1 via post-
translational modifications could be one contributing fac-
tor. Various modification sites have so far been identified
within PARP1, including phosphorylation sites within its
catalytic domain (84,85) and several of these modifications
have already been shown to alter PARP1 activity in gen-
eral (86,87). Additionally, a level of regulation via accessory
factors has recently been discovered, showing that HPF1
extends the catalytic core of PARP enzymes by forming a
composite active site and thereby switching the amino acid
specificity for PARylation from aspartate and glutamate to
serine residues in case of DNA damage (12). A striking ex-
ample for the importance of allosteric interactions is given
by Zandarashvili et al., demonstrating how the affinity of
PARP1 to DNA strand breaks can be modulated by al-
losteric signals conveyed via its helical domain (88). Taken
together, it appears rather likely that some modifications
and/or interactions might also influence PARP1 activity
with regards to branching and chain length. Relating to the
point of regulation, another possible explanation for the ob-
served PAR heterogeneity in mammalian tissues could be
differential expression and/or activity of members of the
PARP family. First evidence in this direction is provided
by Chen et al. (51), connecting PARP2 to the formation of
branched PAR.
CONCLUSION
This study provides insights into a potential biological func-
tion of PAR heterogeneity. By applying PARP1 variants
as a tool to analyze differently structured PAR chains, we
demonstrate that distinct modulations of PARP1 activity
can have severe effects on cellular physiology, such as cell
adhesion, proliferation, cell cycle regulation and cell death,
as well as intracellular molecular processes, such as protein
localization dynamics and gene expression profiles. Since
complete inhibition of PARP1 catalytic activity was bet-
ter tolerated by cells than expression of the PARP1\G972R
variant, the significance of a correct PAR structure becomes
strikingly apparent. We hypothesize that PAR branching
may be at a certain level of saturation in a cellular sys-
tem, with no additional beneficial effect of more strongly
branched PAR, but detrimental effects of lesser branched
PAR. Accordingly, the development of compounds, which
modulate PARP1 activity instead of inhibiting it, and - tak-
ing into account possible differences in expression and ac-
tivity of PARP family members in various tissues - fur-
ther development of homolog-specific inhibitors and organ-
specific inhibition of PARPs, might offer strategies for new
therapeutic approaches.
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